Trials / Sponsors / Yuankai Shi
Yuankai Shi
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China Head and Neck Squamous Cell Carcinoma | Phase 2 | 2021-04-30 |
| Unknown | Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma Peripheral T Cell Lymphoma | Phase 2 | 2016-09-01 |
| Unknown | Chidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer | Phase 2 | 2016-06-01 |